BANK OF AMERICA CORP /DE/ - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 25 filers reported holding ALZAMEND NEURO INC in Q1 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q1 2023$112
-36.0%
264
-14.8%
0.00%
Q4 2022$175
-91.2%
310
-81.6%
0.00%
Q3 2022$2,000
+100.0%
1,686
-0.4%
0.00%
Q2 2022$1,000
-97.1%
1,692
-94.0%
0.00%
Q1 2022$35,00028,1970.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q1 2022
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$59,2500.00%
TRUIST FINANCIAL CORP 2,314,907$548,6330.00%
XTX Topco Ltd 12,974$3,0750.00%
UBS Group AG 7,927$1,8790.00%
IFP Advisors, Inc 5,000$1,1850.00%
OSAIC HOLDINGS, INC. 1,000$2370.00%
FMR LLC 268$640.00%
WELLS FARGO & COMPANY/MN 495$1170.00%
NORTHERN TRUST CORP 103,775$24,5950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALZAMEND NEURO INC shareholders